10-KPeriod: FY2017

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2017

Filed February 13, 2018For Securities:UNH

Summary

UnitedHealth Group's 2017 10-K filing reveals a strong financial performance driven by robust growth across its UnitedHealthcare and Optum segments. The company demonstrated significant revenue increases, bolstered by expansion in Medicare Advantage and Medicaid, alongside consistent growth in its health services arm, Optum. Diluted earnings per share saw a substantial jump, partly attributed to the Tax Cuts and Jobs Act, which positively impacted the company's tax rate. Strategically, UnitedHealth Group continues to leverage its dual platform approach, with UnitedHealthcare offering diversified health benefits and Optum providing a suite of health services. The company's commitment to innovation is evident in its increasing engagement with value-based care models and its continuous investment in technology and data analytics. Despite facing pressures in Medicare Advantage funding and the return of the Health Insurance Industry Tax, UnitedHealth Group maintains a positive outlook, focusing on operational efficiency and member-focused care to drive future growth and profitability.

Financial Statements
Beta
Revenue$201.16B
Cost of Revenue$24.11B
Gross Profit$177.05B
SG&A Expenses$29.56B
Operating Expenses$185.95B
Operating Income$15.21B
Interest Expense$1.19B
Net Income$10.56B
EPS (Basic)$10.95
EPS (Diluted)$10.72
Shares Outstanding (Basic)964.00M
Shares Outstanding (Diluted)985.00M

Key Highlights

  • 1Consolidated revenues increased by 9% to $201.16 billion, driven by 10% growth in UnitedHealthcare and 9% growth in Optum.
  • 2Diluted earnings per share (EPS) rose significantly by 48% to $10.72, with $1.22 of this increase attributable to the Tax Cuts and Jobs Act.
  • 3UnitedHealthcare segment experienced strong membership growth, particularly in Medicare Advantage (up 22%) and Medicaid (up 14%).
  • 4Optum segment reported solid revenue and earnings growth across all its sub-segments: OptumHealth, OptumInsight, and OptumRx.
  • 5Cash flows from operations were robust, increasing by 39% to $13.6 billion, indicating strong operational cash generation.
  • 6The company returned significant capital to shareholders through dividends ($2.77 billion) and share repurchases ($1.5 billion) in 2017.

Frequently Asked Questions

Revenue growth was primarily driven by organic membership increases across UnitedHealthcare's benefit offerings, particularly in Medicare Advantage and Medicaid programs, and growth in Optum's health services. This was partially offset by reduced participation in individual ACA-compliant products and the temporary moratorium on the Health Insurance Industry Tax.

The Tax Cuts and Jobs Act, enacted in December 2017, reduced the U.S. corporate income tax rate. This resulted in a $1.2 billion reduction to the company's net deferred tax liability and a corresponding increase in earnings for 2017. The company projected an effective tax rate of approximately 24% for 2018.

Key risks include the effective management of medical costs, as they represent a significant portion of premium revenue. Regulatory changes and uncertainties, particularly concerning Medicare Advantage funding rates and potential modifications to the Affordable Care Act, pose ongoing challenges. Additionally, the company faces risks related to cybersecurity, data privacy, competition, and maintaining strong relationships with healthcare providers.

UnitedHealth Group actively manages its capital through cash flows from operations, debt, and equity. In 2017, the company paid $2.77 billion in dividends and repurchased $1.5 billion of its common stock. The Board of Directors also increased the quarterly cash dividend, reflecting confidence in the company's financial health and commitment to shareholder returns.